EP1888835A2 - Procede de desencollage - Google Patents

Procede de desencollage

Info

Publication number
EP1888835A2
EP1888835A2 EP05826499A EP05826499A EP1888835A2 EP 1888835 A2 EP1888835 A2 EP 1888835A2 EP 05826499 A EP05826499 A EP 05826499A EP 05826499 A EP05826499 A EP 05826499A EP 1888835 A2 EP1888835 A2 EP 1888835A2
Authority
EP
European Patent Office
Prior art keywords
amylase
alpha
seq
fabric
cbd
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05826499A
Other languages
German (de)
English (en)
Other versions
EP1888835A4 (fr
Inventor
Guifang 9 Anningzhuang West Road Haidian WU
Jiyin Liu
Sonja Salmon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novozymes North America Inc
Original Assignee
Novozymes North America Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes North America Inc filed Critical Novozymes North America Inc
Publication of EP1888835A2 publication Critical patent/EP1888835A2/fr
Publication of EP1888835A4 publication Critical patent/EP1888835A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • D—TEXTILES; PAPER
    • D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06L—DRY-CLEANING, WASHING OR BLEACHING FIBRES, FILAMENTS, THREADS, YARNS, FABRICS, FEATHERS OR MADE-UP FIBROUS GOODS; BLEACHING LEATHER OR FURS
    • D06L1/00—Dry-cleaning or washing fibres, filaments, threads, yarns, fabrics, feathers or made-up fibrous goods
    • D06L1/12—Dry-cleaning or washing fibres, filaments, threads, yarns, fabrics, feathers or made-up fibrous goods using aqueous solvents
    • D06L1/14—De-sizing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411—Amylases
    • C12N9/2414—Alpha-amylase (3.2.1.1.)
    • C12N9/2417—Alpha-amylase (3.2.1.1.) from microbiological source
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411—Amylases
    • C12N9/2414—Alpha-amylase (3.2.1.1.)
    • C12N9/2417—Alpha-amylase (3.2.1.1.) from microbiological source
    • C12N9/242—Fungal source
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01001—Alpha-amylase (3.2.1.1)
    • D—TEXTILES; PAPER
    • D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M16/00—Biochemical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. enzymatic
    • D06M16/003—Biochemical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. enzymatic with enzymes or microorganisms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand

Definitions

  • the present invention relates to a process of desizing sized fabrics during manufacture of especially new fabrics.
  • the processing of a fabric, such as of a cellulosic material, into material ready for garment manufacture involves several steps: spinning of the fiber into a yarn; construction of woven or knit fabric from the yam; and subsequent preparation, dyeing and finishing operations.
  • the preparation process which may involve desizing
  • Alkaline alpha-amylases are used as auxiliaries in desizing processes to facilitate the removal of starch-containing size which has served as a protective coating on yarns during weaving. Complete removal of the size coating after weaving is important to ensure optimum results in the subsequent processes in which the fabric is generally scoured, bleached, dyed and/or printed.
  • Demineralization is typically accomplished by acid precipitation and typically involves addition of acids such as acetic acid or sulphuric acid.
  • the present invention is directed towards providing a process of desizing a sized fabric during manufacture of especially new fabrics.
  • the invention relates to a process for desizing a sized fabric containing starch or starch derivatives during manufacture of a fabric, which process comprises incubating said sized fabric in an aqueous treating solution having a pH in the range between 1 and 5 which aqueous treating solution comprises an alpha- amylase.
  • aqueous treating solution having a pH in the range between 1 and 5 which aqueous treating solution comprises an alpha- amylase.
  • a pH adjusting step is avoided.
  • Another advantage of the invention is that process time is saved/reduced as desizing and demineralization may be carried out simultaneously. Even if the desizing and demineralization are not carried out as a one step process, i.e., simultaneously, costs of, e.g., acids and manpower for adding acid(s) are saved/reduced as the pH adjustment step between the traditional alkaline desizing step and the demineralization step is avoided.
  • fabric is used interchangeable with the term “textile” and means, in contrast to "used” laundry fabric, newly manufactured, preferably undyed, fabrics, garments, fibres, yarns or other types of processed fabrics.
  • Fabrics can be constructed from fibers by weaving, knitting or non-woven operations. Weaving and knitting require yarn as the input whereas the non-woven fabric is the result of random bonding of fibers (paper can be thought of as non- woven).
  • Woven fabric is constructed by weaving "filling" or weft yarns between warp yarns stretched in the longitudinal direction on the loom.
  • the wrap yarns must be sized before weaving in order to lubricate and protect them from abrasion at the high speed insertion of the filling yarns during weaving.
  • the filling yarn can be woven through the warp yarns in a "over one - under the next" fashion (plain weave) or by "over one - under two" (twill) or any other myriad of permutations.
  • Strength, texture and pattern are related not only to the type/quality of the yarn but also the type of weave. Generally, dresses, shirts, pants, sheeting's, towels, draperies, etc. are produced from woven fabric.
  • Knitting is forming a fabric by joining together interlocking loops of yarn.
  • weaving which is constructed from two types of yarn and has many "ends"
  • knitted fabric is produced from a single continuous strand of yarn.
  • Non-woven fabrics are sheets of fabric made by bonding and/or interlocking fibers and filaments by mechanical, thermal, chemical or solvent mediated processes.
  • the resultant fabric can be in the form of web-like structures, laminates or films.
  • Typical examples are disposable baby diapers, towels, wipes, surgical gowns, fibers for the "environmental friendly” fashion, filter media, bedding, roofing materials, backing for two-dimensional fabrics and many others.
  • the process may be applied to any sized fabric known in the art (woven, knitted, or non-woven).
  • the process is applied to newly manufactured sized fabric, as opposed to used and/or soiled fabric to be cleaned during laundry washing.
  • the fabric is made of fibres of natural and/or man-made origin.
  • the fabric is made of fibres from animal origin.
  • the process of the invention may be applied to cellulose- containing or cellulosic fabrics, such as cotton, viscose, rayon, ramie, linen, cellulose acetate, denim, lyocell (TencelTM, e.g., produced by Courtaulds Fibers), or mixtures thereof, or mixtures of any of these fibers together with synthetic fibres (e.g., polyester, polyamid, acrylic, or polyurethane, nylon, poly(ethylene terephthalate) or poly(lactic acid) or other natural fibers, such as wool and silk., such as viscose/cotton blends, lyocell/cotton blends, viscose/wool blends, lyocell/wool blends, cotton/wool blends; flax (linen), ramie and other fabrics based on cellulose fibers, including all blends of cellulosic fibers with other fibers such as wool, polyamide, acrylic and polyester fibers, e.g., viscos
  • the process may also be used on synthetic fabric, e.g., consisting of essentially 100% polyester, polyamid, nylon, respectively.
  • the term "wool,” means any commercially useful animal hair product, for example, wool from sheep, camel, rabbit, goat, lama, and known as merino wool, Shetland wool, cashmere wool, alpaca wool, mohair, etc. and includes wool fiber and animal hair.
  • the process of the invention can be used with wool or animal hair material in the form of top, fiber, yarn, or woven or knitted fabric.
  • the alpha-amylase used in accordance with the process of the invention may be any alpha-amylase, but is preferably of either bacterial or fungal origin.
  • the alpha-amylase is an acid alpha-amylase, such as an acid alpha-amylase derived from a filamentous fungus, especially a strain of the genera Aspergillus, Rhizomucor or Meripillus.
  • the term "acid alpha-amylase” means an alpha-amylase (E. C. 3.2.1.1) which has an optimum activity at a pH in the range of 1 to 7, preferably from 1 to 5 at a temperature of 5O 0 C.
  • deizing is intended to be understood in a conventional manner, i.e., the degradation and/or removal of sizing agents from fabric, such as warp yarns in a woven fabric.
  • fabric containing starch or starch derivatives is intended to indicate any type of fabric, in particular woven fabric prepared from a cellulose-containing material, containing starch or starch derivatives.
  • the fabric is normally undyed and made of cotton, viscose, flax, and the like.
  • the main part of the starch or starch derivatives present on the fabric is normally size with which the yarns, normally warp yarns, have been coated prior to weaving.
  • CBM carbohydrate-binding module
  • CBD carbohydrate-binding domain
  • an effective amount means an amount of, e.g., alpha- amylase that is capable of providing the desired effect, i.e., desizing of the fabric, as compared to a fabric which has not been treated with said enzyme(s).
  • Fig. 1 shows the desizing performance of Alpha-Amylase D on Vlisco fabric at pH 4.0.
  • Fig. 2 shows the desizing performance of Alpha-Amylase C on Vlisco fabric at pH 4.0.
  • the present invention is directed towards providing a process of desizing a sized fabric during manufacture of especially new fabrics.
  • the desizing step of the invention is in a preferred embodiment followed by a scouring step, preferable an enzymatic scouring step, preferably with a scouring enzyme such as a pectinase, e.g., a pectate lyase, a lipase, a protease, or combination thereof, and a bleaching step, preferably involving bleaching with hydrogen peroxide and/or a hydrogen peroxide generating agent.
  • a scouring enzyme such as a pectinase, e.g., a pectate lyase, a lipase, a protease, or combination thereof
  • a bleaching step preferably involving bleaching with hydrogen peroxide and/or a hydrogen peroxide generating agent.
  • Relevant scouring processes are described in US patent no. 5,578,489, US patent no. 5,912,407, and US patent no. 6,630,342.
  • Relevant bleach processes are
  • fabric may be desized and demineralised simultaneously in the same aqueous treating solution or subsequently in the same or two separate treating solutions.
  • desizing and demineralization are carried out simultaneously in the same treating solution.
  • the process of the invention may be carried out using traditional sizing/desizing equipment, e.g., pad systems, J-boxes, jets, jiggers, etc. In general, no additional process equipment is needed.
  • simultaneous desizing and demineralisation are carried out by incubating sized fabric in an aqueous treating solution having a pH in the range between 1 and 5 which aqueous treating solution comprises an alpha- amylase.
  • aqueous treating solution comprises an alpha- amylase.
  • the pH during incubation is in the range between 1 and 4, especially between pH 2 and 4.
  • Woven goods are the prevalent form of fabric construction.
  • the weaving process demands a "sizing" of the warp yarn to protect it from abrasion.
  • Starches, unmodified and modified, polyvinyl alcohol (PVA), carboxy methyl cellulose (CMC), waxes and acrylic binders, and mixtures thereof, are examples of typically used sizing agents.
  • the sizing agent may according to the invention be a starch-based or starch derivative-based sizing agent, but may also contain one or more non-starch or starch derivative-based sizing agents.
  • the sizing agent(s) are in general removed after the weaving process as the first step in preparing the woven goods.
  • One or more other agents including stabilizers, surfactants, wetting agents, dispersing agent, sequestering agents and emulsifying agents, or mixtures thereof, may be present during a desizing process of the invention.
  • the sized fabric is allowed to incubate in the aqueous treating solution for a sufficiently long period of time to accomplish desizing of the sized fabric.
  • the optimal period is dependent upon the type of processing regime and the temperature and can vary from about 15 minutes to several days, e.g., 48 hours.
  • a process of the invention is preferably carried out at a temperature in the range from 5 to 9O 0 C, in particular 20 to 9O 0 C dependent on the processing regime.
  • the processing regime can be either batch or continuous with the fabric being contacted by the aqueous treating stream in open width or rope form.
  • Continuous operations may use a saturator whereby an approximate equal weight of treating solution per weight of fabric is applied to the fabric, followed by a heated dwell chamber where the chemical reaction takes place. A washing section then prepares the fabric for the next processing step.
  • the desizing enzyme(s) and other agents must be thoroughly removed.
  • Batch processes may take place in one bath (treating solution) whereby the fabric is contacted with, e.g., approximately 8-15 times its weight of aqueous treating solution. After an incubation period, the aqueous treating solution is drained, the fabric is rinsed, and the next processing step is initiated.
  • Discontinuous PB- processes i.e., pad-batch processes
  • a saturator whereby an approximate equal weight of aqueous treating solution per weight of fabric is applied to the fabric, followed by a dwell period, which in the case of CPB-process (i.e., cold pad-batch process) might be one or more days.
  • a CPB-process may be carried out at between 20-40 0 C for 8-24 hours or more at a pH in the range between 1 and 5, preferably at a pH in the range between around 1 and 4, especially between pH 2 and 4.
  • a PB-process may be carried out at between 40-90 0 C for 1-6 hours at a pH in the range between around 1 and 5, preferably between around pH 1 and 4, especially between pH 2 and 4.
  • the desizing process of the invention may be carried out using an effective amount of alpha-amylase, preferably acid alpha-amylase, and an acid such as acetic acid or sulphuric acid or the like.
  • a detergent is synonymous with a surfactant, and it may in particular be a non-ionic surfactant, an anionic surfactant, a cationic surfactant, an ampholytic surfactant, a zwitterionic surfactant, and a semi-polar surfactant, or a mixture hereof.
  • the surfactant is typically present in a composition of the invention at a level from 0.1% to 60% by weight.
  • the surfactant is preferably formulated to be compatible with enzyme components present.
  • the surfactant is most preferably formulated in such a way that it promotes, or at least does not degrade, the stability of any enzyme in these compositions.
  • Preferred systems to be used according to the present invention comprise as a surfactant one or more of the non-ionic and/or anionic surfactants described herein.
  • Polyethylene, polypropylene, and polybutylene oxide condensates of alkyl phenols are suitable for use as the non-ionic surfactant of the surfactant systems of the present invention, with the polyethylene oxide condensates being preferred.
  • These compounds include the condensation products of alkyl phenols having an alkyl group containing from about 6 to about 14 carbon atoms, preferably from about 8 to about 14 carbon atoms, in either a straight chain or branched-chain configuration with the alkylene oxide.
  • the ethylene oxide is present in an amount equal to from about 2 to about 25 moles, more preferably from about 3 to about 15 moles, of ethylene oxide per mole of alkyl phenol.
  • non-ionic surfactants of this type include IgepalTM CO- 630, marketed by the GAF Corporation; and TRITONTM X-45, X-114, X-100 and X- 102, all marketed by the Rohm & Haas Company. These surfactants are commonly referred to as alkylphenol alkoxylates (e.g., alkyl phenol ethoxylates).
  • the condensation products of primary and secondary aliphatic alcohols with about 1 to about 25 moles of ethylene oxide are suitable for use as the nonionic surfactant of the non-ionic surfactant system.
  • the alkyl chain of the aliphatic alcohol can either be straight or branched, primary or secondary, and generally contains from about 8 to about 22 carbon atoms.
  • About 2 to about 7 moles of ethylene oxide and most preferably from 2 to 5 moles of ethylene oxide per mole of alcohol are present in said condensation products.
  • non- ionic surfactants of this type examples include TERGITOLTM 15-S-9 (The condensation product of C 11 -C 15 linear alcohol with 9 moles ethylene oxide), TERGITOLTM 24-L-6 NMW (the condensation product of Ci 2 -C 14 primary alcohol with 6 moles ethylene oxide with a narrow molecular weight distribution), both marketed by Union Carbide Corporation;
  • NEODOLTM 45-9 (the condensation product of C 14 -C 15 linear alcohol with 9 moles of ethylene oxide), NEODOLTM 23-3 (the condensation product of C 12 -C 13 linear alcohol with 3.0 moles of ethylene oxide), NEODOLTM 45-7 (the condensation product of C 14 - C 15 linear alcohol with 7 moles of ethylene oxide), NEODOLTM 45-5 (the condensation product of C 14 -C 15 linear alcohol with 5 moles of ethylene oxide) marketed by Shell Chemical Company, KYROTM EOB (the condensation product of C 13 -C 15 alcohol with 9 moles ethylene oxide), marketed by The Procter & Gamble Company, and Genapol LA 050 (the condensation product of C 12 -Ci 4 alcohol with 5 moles of ethylene oxide) marketed by Hoechst. Preferred range of HLB in these products is from 8-11 and most preferred from 8-10.
  • alkylpolysaccharides disclosed in US 4,565,647, having a hydrophobic group containing from about 6 to about 30 carbon atoms, preferably from about 10 to about 16 carbon atoms and a polysaccharide, e.g., a polyglycoside, hydrophilic group containing from about 1.3 to about 10, preferably from about 1.3 to about 3, most preferably from about 1.3 to about 2.7 saccharide units.
  • Any reducing saccharide containing 5 or 6 carbon atoms can be used, e.g., glucose, galactose and galactosyl moieties can be substituted for the glucosyl moieties (optionally the hydrophobic group is attached at the 2-, 3-, 4-, etc. positions thus giving a glucose or galactose as opposed to a glucoside or galactoside).
  • the intersaccharide bonds can be, e.g., between the one position of the additional saccharide units and the 2-, 3-, 4-, and/or 6- positions on the preceding saccharide units.
  • the preferred alkylpolyglycosides have the formula
  • R 2 0(C n H 2n O) t (glycosyl) x
  • R 2 is selected from the group consisting of alkyl, alkylphenyl, hydroxyalkyl, hydroxyalkylphenyl, and mixtures thereof in which the alkyl groups contain from about 10 to about 18, preferably from about 12 to about 14, carbon atoms; n is 2 or 3, preferably 2; t is from 0 to about 10, preferably 0; and x is from about 1.3 to about 10, preferably from about 1.3 to about 3, most preferably from about 1.3 to about 2.7.
  • the glycosyl is preferably derived from glucose.
  • the alcohol or alkylpolyethoxy alcohol is formed first and then reacted with glucose, or a source of glucose, to form the glucoside (attachment at the 1 -position).
  • the additional glycosyl units can then be attached between their 1 -position and the preceding glycosyl units 2-, 3-, A-, and/or 6-position, preferably predominantly the 2- position.
  • the condensation products of ethylene oxide with a hydrophobic base formed by the condensation of propylene oxide with propylene glycol are also suitable for use as the additional non-ionic surfactant system.
  • the hydrophobic portion of these compounds will preferably have a molecular weight from about 1500 to about 1800 and will exhibit water insolubility.
  • the addition of polyoxyethylene moieties to this hydrophobic portion tends to increase the water solubility of the molecule as a whole, and the liquid character of the product is retained up to the point where the polyoxyethylene content is about 50% of the total weight of the condensation product, which corresponds to condensation with up to about 40 moles of ethylene oxide.
  • Examples of compounds of this type include certain of the commercially available
  • PLURONICTM surfactants marketed by BASF.
  • non-ionic surfactant of the non-ionic surfactant system are condensation products of ethylene oxide with the product resulting from the reaction of propylene oxide and ethylenediamine.
  • the hydrophobic moiety of these products consists of the reaction product of ethylenediamine and excess propylene oxide, and generally has a molecular weight of from about 2,500 to about 3,000. This hydrophobic moiety is condensed with ethylene oxide to the extent that the condensation product contains from about 40% to about 80% by weight of polyoxyethylene and has a molecular weight of from about 5,000 to about 11 ,000.
  • Examples of this type of non-ionic surfactant include certain of the commercially available TETRONICTM compounds, marketed by BASF.
  • Preferred for use as the non-ionic surfactant of the surfactant system are polyethylene oxide condensates of alkyl phenols, condensation products of primary and secondary aliphatic alcohols with from about 1 to about 25 moles of ethyleneoxide, alkylpolysaccharides, and mixtures hereof. Most preferred are C 8 -C 14 alkyl phenol ethoxylates having from 3 to 15 ethoxy groups and C 8 -C 18 alcohol ethoxylates (preferably C 10 avg.) having from 2 to 10 ethoxy groups, and mixtures thereof.
  • Highly preferred non-ionic surfactants are polyhydroxy fatty acid amide surfactants of the formula
  • R 1 wherein R 1 is H, or R 1 is C 1-4 hydrocarbyl, 2-hydroxyethyl, 2-hydroxypropyl or a mixture thereof, R 2 is C 5-31 hydrocarbyl, and Z is a polyhydroxyhydrocarbyl having a linear hydrocarbyl chain with at least 3 hydroxyls directly connected to the chain, or an alkoxylated derivative thereof.
  • R 1 is methyl
  • R 2 is straight C 11-I5 alkyl or C 16- - I8 alkyl or alkenyl chain such as coconut alkyl or mixtures thereof
  • Z is derived from a reducing sugar such as glucose, fructose, maltose or lactose, in a reductive amination reaction.
  • Highly preferred anionic surfactants include alkyl alkoxylated sulfate surfactants.
  • Examples hereof are water soluble salts or acids of the formula RO(A) m SO3M wherein R is an unsubstituted C 10 -C- 24 alkyl or hydroxyalkyl group having a C 10 -C 24 alkyl component, preferably a C 12 -C 20 alkyl or hydroxyalkyl, more preferably Ci 2 -C 18 alkyl or hydroxyalkyl, A is an ethoxy or propoxy unit, m is greater than zero, typically between about 0.5 and about 6, more preferably between about
  • M is H or a cation which can be, for example, a metal cation (e.g., sodium, potassium, lithium, calcium, magnesium, etc.), ammonium or sub- stituted-ammonium cation.
  • a metal cation e.g., sodium, potassium, lithium, calcium, magnesium, etc.
  • ammonium or sub- stituted-ammonium cation e.g., sodium, potassium, lithium, calcium, magnesium, etc.
  • Alkyl ethoxylated sulfates as well as alkyl propoxylated sulfates are contemplated herein.
  • substituted ammonium ca- tions include methyl-, dimethyl, trimethyl-ammonium cations and quaternary ammonium cations such as tetramethyl-ammonium and dimethyl piperdinium cations and those derived from alkylamines such as ethylamine, diethylamine, triethylamine, mixtures thereof, and the like.
  • Exemplary surfactants are C 12 -Ci 8 alkyl polyethoxylate (1.0) sulfate (C 12 -C 18 E(LO)M), C 12 -C 18 alkyl polyethoxylate (2.25) sulfate (C 12 - C 18 (2.25)M, and C 12 -C 18 alkyl polyethoxylate (3.0) sulfate (C 12 -C 18 E(3.0)M), and C 12 -
  • C 18 alkyl polyethoxylate (4.0) sulfate (C 12 -C 18 E(4.0)M), wherein M is conveniently selected from sodium and potassium.
  • Suitable anionic surfactants to be used are alkyl ester sulfonate surfactants including linear esters of C 8 -C 20 carboxylic acids (i.e., fatty acids) which are sulfona- ted with gaseous SO 3 according to "The Journal of the American Oil Chemists Society", 52 (1975), pp. 323-329.
  • Suitable starting materials would include natural fatty substances as derived from tallow, palm oil, etc.
  • alkyl ester sulfonate surfactant comprise alkyl ester sulfonate surfactants of the structural formula: O
  • R 3 is a C 8 -C 20 hydrocarbyl, preferably an alkyl, or combination thereof
  • R 4 is a C 1 -C 6 hydrocarbyl, preferably an alkyl, or combination thereof
  • M is a cation which forms a water soluble salt with the alkyl ester sulfonate.
  • Suitable salt-forming cations include metals such as sodium, potassium, and lithium, and substituted or unsubstituted ammonium cations, such as monoethanolamine, diethonolamine, and triethanolamine.
  • R 3 is C 10 -C 16 alkyl
  • R 4 is methyl, ethyl or isopropyl.
  • methyl ester sulfonates wherein R 3 is C 10 -Ci 6 alkyl.
  • alkyl sulfate surfactants which are water soluble salts or acids of the formula ROSO 3 M wherein R preferably is a C 10 -C 24 hydrocarbyl, preferably an alkyl or hydroxyalkyl having a C 10 -C 20 alkyl component, more preferably a C 12 -C 18 alkyl or hydroxyalkyl, and M is H or a cation, e.g., an alkali metal cation (e.g., sodium, potassium, lithium), or ammonium or substituted ammonium (e.g., methyl-, dimethyl-, and trimethyl ammonium cations and quaternary ammonium cations such as tetramethyl-ammonium and dimethyl piperdinium cations and quaternary ammonium cations derived from alkylamines such as ethylamine, diethylamine, triethylamine, and mixtures thereof, and the like).
  • R preferably is a C
  • anionic surfactants useful for detersive purposes include salts (including, for example, sodium, potassium, ammonium, and substituted ammonium salts such as mono- di- and triethanolamine salts) of soap, C 8 -C 22 primary or secondary alkanesulfonates, C 8 -C 24 olefinsulfonates, sulfonated polycarboxylic acids prepared by sulfonation of the pyrolyzed product of alkaline earth metal citrates, e.g., as described in British patent specification No.
  • alkylpo- lyglycolethersulfates (containing up to 10 moles of ethylene oxide); alkyl glycerol sulfonates, fatty acyl glycerol sulfonates, fatty oleyl glycerol sulfates, alkyl phenol ethylene oxide ether sulfates, paraffin sulfonates, alkyl phosphates, isethionates such as the acyl isethionates, N-acyl taurates, alkyl succinamates and sulfosuccinates, monoesters of sulfosuccinates (especially saturated and unsaturated C 12 -C 18 monoesters) and diesters of sulfosuccinates (especially saturated and unsaturated C 6 -C 12 diesters), acyl sarcosinates, sulfates of alkylpolysaccharides such
  • Alkylbenzene sulfonates are highly preferred. Especially preferred are linear (straight-chain) alkyl benzene sulfonates (LAS) wherein the alkyl group preferably contains from 10 to 18 carbon atoms.
  • LAS linear (straight-chain) alkyl benzene sulfonates
  • compositions of the present invention typically comprise from about 1 % to about 40%, preferably from about 3% to about 20% by weight of such anionic surfactants.
  • compositions of the present invention may also contain cationic, ampholytic, zwitterionic, and semi-polar surfactants, as well as the nonionic and/or anionic surfactants other than those already described herein.
  • Cationic detersive surfactants suitable for use in the compositions of the present invention are those having one long-chain hydrocarbyl group.
  • cationic surfactants include the ammonium surfactants such as alkyltrimethylammonium halogenides, and those surfactants having the formula:
  • R 2 is an alkyl or alkyl benzyl group having from about 8 to about 18 carbon atoms in the alkyl chain, each R 3 is selected form the group consisting of -CH 2 CH 2 -, -
  • each R 4 is selected from the group consisting of C 1 -C 4 alkyl, C 1 -C 4 hydroxyalkyl, benzyl ring structures formed by joining the two R 4 groups, -CH 2 CHOHCHOHCOR 6 CHOHCH- 2 0H, wherein R 6 is any hexose or hexose polymer having a molecular weight less than about 1000, and hydrogen when y is not 0; R 5 is the same as R 4 or is an alkyl chain.wherein the total number of carbon atoms or R 2 plus R 5 is not more than about 18; each y is from 0 to about 10, and the sum of the y values is from 0 to about 15; and X is any compatible anion.
  • Highly preferred cationic surfactants are the water soluble quaternary ammonium compounds useful in the present composition having the formula:
  • the preferred alkyl chain length for R 1 is C 12 -C 15 , particularly where the alkyl group is a mixture of chain lengths derived from coconut or palm kernel fat or is derived synthetically by olefin build up or OXO alcohols synthesis.
  • R 2 R 3 and R 4 are methyl and hydroxyethyl groups and the anion X may be selected from halide, methosulphate, acetate and phosphate ions.
  • suitable quaternary ammonium compounds of formulae (i) for use herein are: coconut trimethyl ammonium chloride or bromide; coconut methyl dihydroxyethyl ammonium chloride or bromide; decyl triethyl ammonium chloride; decyl dimethyl hydroxyethyl ammonium chloride or bromide;
  • compositions of the present invention typically comprise from 0.2% to about 25%, preferably from about 1% to about 8% by weight of such cationic surfactants.
  • Ampholytic surfactants are also suitable for use in the compositions of the present invention. These surfactants can be broadly described as aliphatic derivatives of secondary or tertiary amines, or aliphatic derivatives of heterocyclic secondary and tertiary amines in which the aliphatic radical can be straight- or branched-chain.
  • One of the aliphatic substituents contains at least about 8 carbon atoms, typically from about 8 to about 18 carbon atoms, and at least one contains an anionic water-solubilizing group, e.g., carboxy, sulfonate, sulfate. See US 3,929,678 (column 19, lines 18-35) for examples of ampholytic surfactants.
  • compositions of the present invention typically comprise from 0.2% to about 15%, preferably from about 1 % to about 10% by weight of such ampholytic surfactants.
  • Zwitterionic surfactants are also suitable for use in the composition of the invention. These surfactants can be broadly described as derivatives of secondary and tertiary amines, derivatives of heterocyclic secondary and tertiary amines, or derivatives of quaternary ammonium, quaternary phosphonium or tertiary sulfonium compounds. See US 3,929,678 (column 19, line 38 through column 22, line 48) for examples of zwitterionic surfactants.
  • compositions of the present invention typically comprise from 0.2% to about 15%, preferably from about 1% to about 10% by weight of such zwitterionic surfactants.
  • Semi-polar nonionic surfactants are a special category of nonionic surfactants which include water-soluble amine oxides containing one alkyl moiety of from about 10 to about 18 carbon atoms and 2 moieties selected from the group consisting of alkyl groups and hydroxyalkyl groups containing from about 1 to about 3 carbon atoms; watersoluble phosphine oxides containing one alkyl moiety of from about 10 to about 18 carbon atoms and 2 moieties selected from the group consisting of alkyl groups and hydroxyalkyl groups containing from about 1 to about 3 carbon atoms; and water-soluble sulfoxides containing one alkyl moiety from about 10 to about 18 carbon atoms and a moiety selected from the group consisting of alkyl and hydroxyalkyl moieties of from about 1 to about 3 carbon atoms.
  • R 3 (OR 4 )xN(R 5 )2 wherein R 3 is an alkyl, hydroxyalkyl, or alkyl phenyl group or mixtures thereof containing from about 8 to about 22 carbon atoms; R 4 is an alkylene or hydroxyalkylene group containing from about 2 to about 3 carbon atoms or mixtures thereof; x is from 0 to about 3: and each R 5 is an alkyl or hydroxyalkyl group containing from about 1 to about 3 carbon atoms or a polyethylene oxide group containing from about 1 to about 3 ethylene oxide groups.
  • the R 5 groups can be attached to each other, e.g., through an oxygen or nitrogen atom, to form a ring structure.
  • amine oxide surfactants in particular include C 10 -C 18 alkyl dimethyl amine oxides and C 8 -Ci 2 alkoxy ethyl dihydroxy ethyl amine oxides.
  • composition of the present invention typically comprises from 0.2% to about 15%, preferably from about 1% to about 10% by weight of such semi-polar nonionic surfactants.
  • the alpha-amylase(s) used in the process of the invention may be any alpha- amylase, preferably of bacterial or fungal origin.
  • the alpha-amylase is an acid alpha-amylase, such as an alpha-amylase or hybrid alpha- amylase disclosed in WO 2005/003311 which is hereby incorporated by reference.
  • the alpha-amylase include a carbohydrate-binding module (CBM) as defined in WO 2005/003311 , preferably a family 20 CBM as defined in WO 2005/003311.
  • CBM carbohydrate-binding module
  • CBMs include the ones selected from the group consisting of Aspergillus kawachii disclosed in SEQ ID NO: 2; Bacillus flavothermus disclosed in SEQ ID NO: 5; Bacillus sp. disclosed in SEQ ID NO: 6; Alcaliphilic
  • the fungal alpha-amylase is of yeast or filamentous fungus origin. In a preferred embodiment the fungal alpha-amylase is an acid alpha- amylase.
  • Preferred alpha-amylases include, for example, alpha-amylases obtainable from Aspergillus species, in particular from Aspergillus niger, A. oryzae, and A. awamori, A. kawachii, such as the acid alpha-amylase disclosed as SWISSPROT P56271, or described in more detail in WO 89/01969 (Example 3).
  • the mature acid alpha- amylase has the amino acid sequence shown as 22-511 of SEQ ID NO: 4, encoded by the DNA sequence shown in SEQ ID NO: 3, or the amino acid sequence shown in SEQ ID NO: 38.
  • alpha-amylase sequences having more than 50%, such as more than 60%, more than 70%, more than 80% or more than 90%, more than 95%, more than 96%, more than 97%, more than 98%, or even more than 99% identity to the amino acid sequence shown in SEQ ID NOS: 4 or 38, respectively.
  • the alpha-amylase sequence is derived from an
  • a oryzae acid alpha-amylase More preferably the alpha-amylase sequence has more than 50%, such as more than 60%, more than 70%, more than 80% or more than 90%, more than 95%, more than 96%, more than 97%, more than 98%, or more than 99% identity to the amino acid sequence shown in SEQ ID NO: 39.
  • the alpha-amylase is the Aspergillus kawachii alpha-amylase disclosed in SEQ ID NO: 37, which in wild-type form contains a carbohydrate-binding domain (CBD) also shown in SEQ ID NO: 2.
  • CBD carbohydrate-binding domain
  • the alpha-amylase is an alpha-amylase having more than 50%, such as more than 60%, more than 70%, more than 80% or more than 90%, more than 95%, more than 96%, more than 97%, more than 98%, or even more than
  • the alpha-amylase may be present in a concentration of 1-3,000 AFAU/kg fabric, preferably 10-1 ,000 AFAU/ kg fabric, especially 100-500 AFAU/kg fabric or 1-
  • 3,000 AFAU/L treating solution preferably 10-1 ,000 AFAU/L treating solution, especially 100-500 AFAU/L treating solution.
  • alpha-amylase is of bacterial origin.
  • bacterial alpha-amylase is an acid alpha-amylase.
  • the bacterial alpha-amylase is preferably derived from a strain of Bacillus, such as Bacillus licheniformis, Bacillus amyloliquefaciens, Bacillus stearothermophilus, Bacillus subtilis, or other Bacillus sp., such as Bacillus sp. NCIB 12289, NCIB 12512 (WO 95/26397), NCIB 12513 (WO 95/26397), DSM 9375 (WO 95/26397) , DSMZ
  • the bacterial alpha-amylase is the SP722 alpha-amylase disclosed as SEQ ID NO: 2 in WO 95/26397 or the AA560 alpha- amylase (SEQ ID NO: 40 herein).
  • the parent alpha-amylase has one or more deletions in positions or corresponding to the following positions: D183 and G184, preferably wherein said alpha-amylase variant further has a substitution in position or corresponding to position N195F (using the SEQ ID NO: 40 numbering).
  • the parent alpha-amylase has one or more of the following deletions/substitutions or corresponding to the following deletions/substitutions: Delta (R81-G182); Delta (D183-G184); Delta (D183- G184)+N195F; R181Q+N445Q+K446N; Delta (D183-G184)+R181Q, Delta (D183- G184) and one or more of the following substitutions or corresponding to: R118K, N195F, R320K, R458K, especially wherein the variant has the following mutations:
  • the alpha-amylase is the AA560 alpha- amylase shown in SEQ ID NO: 40 further comprising one or more of the following substitutions M9L, M202L, V214T, M323T, M382Y, E345R or the A560 alpha- amylase with all of the following substitutions: M9L, M202L, V214T, M323T, M382Y or M9L, M202L, V214T, M323T and. E345R.
  • alpha-amylase products or products comprising alpha-amylases include product sold under the following tradenames: NATALASETM, STAINZYMETM (Novozymes A/S), Bioamylase - D(G), BIOAMYLASETM L (Biocon India Ltd.), KEMZYMTM AT 9000(Biozym Ges. m.b.H, Austria), PURASTARTM ST,
  • the alpha-amylase may be present in a concentration of from about 0.05-150 KNU/L treating solution, preferably 1-100 KNU/L treating solution, especially 2-20 KNU/L treating solution or 0.05-150 KNU/Kg fabric, preferably, 1-100 KNU/kg fabric, especially 2-20 KNU/kg fabric
  • the alpha-amylase may in a preferred embodiment be an alpha-amylase comprising a carbohydrate-binding domain (CBD).
  • CBD carbohydrate-binding domain
  • Such alpha-amylase with a CBD may be a wild type enzyme (see e.g., Aspergillus kawachii above) or a hybrid enzyme (fusion protein) as will be described further below.
  • Hybrid enzymes or a genetically modified wild type enzymes as referred to herein include species comprising an amino acid sequence of an alpha-amylase enzyme (EC 3.2.1.1) linked (i.e. covalently bound) to an amino acid sequence comprising a carbohydrate-binding domain (CBD).
  • CBD-containing hybrid enzymes as well as detailed descriptions of the preparation and purification thereof, are known in the art [see, e.g. WO 90/00609, WO
  • the resulting recombinant product (hybrid enzyme) often referred to in the art as a "fusion protein - may be described by the following general formula:
  • A-CBD is the N-terminal or the C-terminal region of an amino acid sequence comprising at least the carbohydrate-binding domain (CBD) per se.
  • MR is the middle region (the "linker")
  • X is the sequence of amino acid residues of a polypeptide encoded by a DNA sequence encoding the enzyme (or other protein) to which the CBD is to be linked.
  • the moiety A may either be absent (such that A-CBD is a CBD per se, i.e. comprises no amino acid residues other than those constituting the CBD) or may be a sequence of one or more amino acid residues (functioning as a terminal extension of the CBD per se).
  • the linker (MR) may be a bond, or a short linking group comprising from about 2 to about 100 carbon atoms, in particular of from 2 to 40 carbon atoms.
  • MR is preferably a sequence of from about 2 to about 100 amino acid residues, more preferably of from 2 to 40 amino acid residues, such as from 2 to 15 amino acid residues.
  • the moiety X may constitute either the N-terminal or the C-terminal region of the overall hybrid enzyme.
  • the CBD in a hybrid enzyme of the type in question may be positioned C-terminally, N-temninally or internally in the hybrid enzyme.
  • the linker sequence may be any suitable linker sequence.
  • the linker sequence is derived from the Athelia rolfsii glucoamylase, the
  • A.niger glucoamylase such as a linker sequence selected from the group consisting of A. niger glucoamylase linker: TGGTTTTATPTGSGSVTSTSKTTATASKTSTSTSSTSA (SEQ ID NO:22), A. kawachii aipha-amylase linker: T T T T T T A A A T S T S K A T T S S S S S S A A A T T S S S (SEQ ID NO:23), Athelia rolfsii glucoamylase linker: G A T S P G G S S G
  • the hybrid enzymes has a linker sequence which differs from the amino acid sequence shown in SEQ ID NO:22, SEQ ID NO:23, SEQ ID NO:24, or SEQ ID NO:25 in no more than 10 positions, no more than 9 positions, no more than 8 positions, no more than 7 positions, no more than 6 positions, no more than 5 positions, no more than 4 positions, no more than 3 positions, no more than 2 positions, or even no more than 1 position.
  • a carbohydrate-binding domains or as often referred to, a carbohydrate- binding modules (CBM) is a polypeptide amino acid sequence which binds preferentially to a poly- or oligosaccharide (carbohydrate), frequently - but not necessarily exclusively - to a water-insoluble (including crystalline) form thereof.
  • CBDs derived from starch degrading enzymes are often referred to as starch- binding domains (SBD) or starch-binding modules (SBM).
  • SBDs are CBDs which may occur in certain amylolytic enzymes, such as certain glucoamylases, or in enzymes such as cyclodextrin glucanotransferases, or in alpha-amylases.
  • other sub-classes of CBDs would embrace, e.g.
  • CBDs cellulose-binding domains from cellulolytic enzymes
  • CBDs which typically occur in chitinases
  • xylan-binding domains CBDs which typically occur in xylanases
  • mannan-binding domains CBDs which typically occur in mannanases
  • CBDs are found as integral parts of large polypeptides or proteins consisting of two or more polypeptide amino acid sequence regions, especially in hydrolytic enzymes (hydrolases) which typically comprise a catalytic domain containing the active site for substrate hydrolysis and a carbohydrate-binding domain (CBD) for binding to the carbohydrate substrate in question.
  • hydrolytic enzymes hydrolytic enzymes
  • CBDs carbohydrate-binding domain
  • Such enzymes can comprise more than one catalytic domain and one, two or three CBDs, and optionally further comprise one or more polypeptide amino acid sequence regions linking the CBD(s) with the catalytic domain(s), a region of the latter type usually being denoted a "linker".
  • hydrolytic enzymes comprising a CBD - some of which have already been mentioned above - are cellulases, xylanases, mannanases, arabinofuranosidases, acetylesterases and chitinases.
  • CBDs have also been found in algae, e.g., in the red alga Porphyra purpurea in the form of a non-hydrolytic polysaccharide-binding protein.
  • a CBD may be located at the N or C terminus or at an internal position. That part of a polypeptide or protein (e.g. hydrolytic enzyme) which constitutes a CBD per se typically consists of more than about 30 and less than about 250 amino acid residues.
  • the "Carbohydrate-Binding Module of Family 20" or a CBM-20 module is in the context of this invention defined as a sequence of approximately 100 amino acids having at least 45% homology to the Carbohydrate-Binding Module (CBM) of the polypeptide disclosed in figure 1 by Joergensen et al (1997) in Biotechnol. Lett. 19:1027-1031.
  • the CBM comprises the last 102 amino acids of the polypeptide, i.e. the subsequence from amino acid 582 to amino acid 683.
  • the numbering of Glycoside Hydrolase Families applied in this disclosure follows the concept of Coutinho, P.M. & Henrissat, B.
  • Examples of enzymes which comprise a CBD suitable for use in the context of the invention are alpha-amylases, maltogenic alpha-amylases, cellulases, xylanases, mannanases, arabinofuranosidases, acetylesterases and chitinases.
  • Further CBDs of interest in relation to the present invention include CBDs derived from glucoamylases (EC 3.2.1.3) or from CGTases (EC 2.4.1.19).
  • CBDs derived from fungal, bacterial or plant sources will generally be suitable for use in the context of the invention.
  • Aspergillus sp. Bacillus sp.
  • Klebsiella sp. or Rhizopus sp.
  • techniques suitable for isolating the relevant genes are well known in the art.
  • Preferred for the invention is CBDs of Carbohydrate-Binding Module Family 20.
  • CBDs of Carbohydrate-Binding Module Family 20 suitable for the invention may be derived from glucoamylases of Aspergillus awamori (SWISSPROT Q12537), Aspergillus kawachii (SWISSPROT P23176), Aspergillus niger (SWISSPROT P04064), Aspergillus oryzae (SWISSPROT P36914), from alpha-amylases of
  • Aspergillus kawachii EBL:#AB008370
  • Aspergillus nidulans NCBI AAF17100.1
  • SWISSPROT P36924 beta-amylases of Bacillus cereus
  • SWISSPROT P43379 CGTases of Bacillus circulans
  • a CBD from the alpha- amylase of Aspergillus kawachii (EMBL:#AB008370) as well as CBDs having at least 50%, 60%, 70%, 80% or even at least 90%, 95%, 96%, 97%, 98%, or 99% identity with the CBD of the alpha-amylase of Aspergillus kawachii (EN ⁇ BL.#AB008370), i.e. a CBD having at least 50%, 60%, 70%, 80% or even at least 90%, 95%, 96%, 97%, 98%, or 99% identity with the amino acid sequence of SEQ ID NO:2.
  • CBDs of Carbohydrate-Binding Module Family 20 having the amino acid sequences shown in SEQ ID NO:5, SEQ ID NO:6, and SEQ ID NO:7 and disclosed in PCT application no. PCT/DK2004/000456 (or Danish patent application PA 2003 00949) as SEQ ID NO:1 , SEQ ID NO:2 and SEQ ID NO:3 respectively.
  • Further preferred CBDs include the CBDs of the glucoamylase from Hormoconis sp. such as from Hormoconis resinae (Syn.
  • Creosote fungus or Amorphotheca resinae such as the CBD in SWISSPROT:Q03045 (SEQ ID NO:8), from Lentinula sp. such as from Lentinula edodes (shiitake mushroom) such as the CBD of SPTREMBLQ9P4C5 (SEQ ID NO:9), from Neurospora sp. such as from Neurospora crassa such as the CBD of SWISSPROT:P14804 (SEQ ID NO: 10), from Talaromyces sp. such as from Talaromyces byssochlamydioides such as the CBD from NN005220 (SEQ ID NO:11), from Geosmithia sp.
  • Geosmithia cylindrospora such as the CBD of NN48286 (SEQ ID NO: 12), from Scorias sp. such as from Scorias spongiosa such as the CBD of NN007096 (SEQ ID NO: 13), from Eupenicillium sp. such as from Eupenicillium ludwigii such as the CBD of NN005968 (SEQ ID NO:14), from Aspergillus sp. such as from Aspergillus japonicus such as the CBD from NN001136 (SEQ ID NO: 15), from Penicillium sp. such as from Penicillium cf.
  • CBDs such as the CBD of NN48691 (SEQ ID NO:16), from Mz1 Penicillium sp. such as the CBD of NN48690 (SEQ ID NO:17), from Thysanophora sp. such as the CBD of NN48711 (SEQ ID NO:18), and from Humicola sp. such as from Humicola grisea van thermoidea such as the CBD of SPTREMBLQ12623 (SEQ ID NO:19).
  • Most preferred CBDs include the CBDs of the glucoamylase from Aspergillus sp. such as from Aspergillus niger, such as SEQ ID NO:20, and Athelia sp.
  • Athelia rolfsu such as SEQ ID NO:21.
  • any CBD having at least 50%, 60%, 70%, 80% or even at least 90%, 95%, 96%, 97%, 98%, or 99% identity to any of the afore mentioned CBD amino acid sequences.
  • CBDs of Carbohydrate-Binding Module Family 20 may be found at URL: http://afmb.cnrs-mrs.fr/ ⁇ cazv/CAZY/index.htmh.
  • the alpha-amylase comprised in the hybrid is an alpha- amylase described above in the "Alpha-amylase"-section.
  • the alpha-amylase is of fungal origin.
  • the alpha- amylase is an acid alpha-amylase.
  • the carbohydrate-binding domain and/or linker sequence is of fungal origin.
  • the carbohydrate-binding domain may be derived from an alpha-amylase, but may also be derived from of proteins, e.g., enzymes having glucoamylase activity.
  • the alpha-amylase is derived from a strain of Aspergillus, or
  • the alpha-amylase is derived from a strain of Aspergillus oryzae or Aspergillus niger. In a specific embodiment the alpha-amylase is the A.oryzae acid alpha-amylase disclosed in SEQ ID NO:39. In a specific embodiment the linker sequence may be derived from a strain of Aspergillus, such as the A. kawachii alpha- amylase (SEQ ID NO: 23) or the A. rolfsii glucoamylase (SEQ ID NO: 24).
  • the CBD is derived from a strain of Aspergillus or Athelia. In a specific embodiment the CBD is the A. kawachii alpha-amylase shown in SEQ ID NO:1 or the A. rolfsii glucoamylase shown in SEQ ID NO:21.
  • the hybrid enzyme comprises an alpha- amylase sequence derived from the A.niger acid alpha-amylase catalytic domain having the sequence shown in SEQ ID NO:38, and/or a linker sequence derived from the A. kawachii alpha-amylase shown in SEQ ID NO: 23 or the A. rolfsii glucoamylase shown in SEQ ID NO: 24, and/or the CBD is derived from the A. kawachii alpha- amylase shown in SEQ ID NO: 2, the A. rolfsii glucoamylase shown in SEQ ID NO: 21 or the A.niger glucoamylase shown in SEQ ID NO: 22.
  • the hybrid enzyme comprises the A.niger acid alpha- amylase catalytic domain having the sequence shown in SEQ ID NO:38, the A. kawachii alpha-amylase linker shown in SEQ ID NO: 23, and A. kawachii alpha- amylase CBD shown in SEQ ID NO:2.
  • the hybrid enzyme is the mature part of the amino acid sequence shown in SEQ ID NO: 28 (A niger acid alpha-amylase catalytic domain- A. kawachii alpha-amylase linker-A n/ger glucoamylase CBD), SEQ ID NO:30 (A. niger acid alpha-amylase catalytic domain-A kawachii alpha-amylase linker-A rolfsii glucoamylase CBD), or SEQ ID NO:32 (A oryzae acid alpha-amylase catalytic domain- A.
  • kawachii alpha-amylase linker-A/cawacM alpha-amylase CBD or SEQ ID NO:34 (A niger acid alpha-amylase catalytic domain-A rolfsii glucoamylase linker-A rolfsii glucoamylase CBD), or SEQ ID NO: 36 (A oryzae acid alpha-amylase catalytic domain-A rolfsii glucoamylase linker-Aro/fs// glucoamylase CBD) or the hybrid consisting of A niger acid alpha-amylase catalytic domain (SEQ ID NOS: 4 or 38, respectively)-A kawachii glucoamylase linker (SEQ ID NO: 23) -Akawachi glucoamylase CBD (SEQ ID NO: 2) or a hybrid enzyme that has an amino acid sequence having at least 50%, 60%, 70%, 80% or even at least 90%, 95%, 96%, 97%
  • the hybrid enzyme has an amino acid sequence which differs from the amino acid sequence amino acid sequence shown in SEQ ID NO:28 (A niger acid alpha-amylase catalytic domain-A kawachii alpha- amylase linker-A niger glucoamylase CBD), SEQ ID NO:30 (A niger acid alpha- amylase catalytic domain-A kawachii alpha-amylase linker-A rolfsii glucoamylase
  • CBD CBD
  • SEQ ID NO:32 A oryzae acid alpha-amylase catalytic domain-A kawachii alpha-amylase linker-A/cawac/?// alpha-amylase CBD
  • SEQ ID NO:34 A niger acid alpha-amylase catalytic domain-A rolfsii glucoamylase linker-A rolfsii glucoamylase CBD
  • SEQ ID NO:36 A oryzae acid alpha-amylase catalytic domain-A rolfsii glucoamylase linker-Aro/fs/7 glucoamylase CBD) or the hybrid consisting of A niger acid alpha-amylase catalytic domain (SEQ ID NOS: 4 or 38, respectively)-A kawachii glucoamylase linker (SEQ ID NO: 23) -A.kawachi glucoamylase CBD (SEQ ID NO: 2) in no more than 10 positions,
  • the hybrid enzyme comprises a CBD sequence having at least 50%, 60%, 70%, 80% or even at least 90%, 95%, 96%, 97%, 98%, or 99% identity to any of the amino acid sequences shown in SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11 , SEQ ID NO:12, SEQ ID NO:
  • the hybrid enzyme comprises a CBD sequence having an amino acid sequence shown in SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11 , SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:15, SEQ ID NO:16, SEQ ID NO:17, SEQ ID NO:18, SEQ ID NO:19, SEQ ID NO:20 or SEQ ID NO:21.
  • the CBD sequence has an amino acid sequence which differs from the amino acid sequence amino acid sequence shown in SEQ ID N0:5, SEQ ID N0:6, SEQ ID N0:7, SEQ ID N0:8, SEQ ID N0:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID N0:12, SEQ ID N0:13, SEQ ID N0:14, SEQ ID N0:15, SEQ ID N0:16, SEQ ID N0:17, SEQ ID N0:18, SEQ ID N0:19, SEQ ID NO:20 or SEQ ID NO:21 in no more than 10 amino acid positions, no more than 9 positions, no more than 8 positions, no more than 7 positions, no more than 6 positions, no more than 5 positions, no more than 4 positions, no more than 3 positions, no more than 2 positions, or even no more than 1 position.
  • the hybrid enzyme comprises a CBD derived from a glucoamylase from A. rolfsii, such as the glucoamylase from A. rolfsii AHU 9627 disclosed in US patent 4,727,026.
  • Acid Alpha-Amylase A Wild-type acid alpha-amylase derived from Aspergillus niger disclosed in SEQ ID NO: 38.
  • Acid Alpha-Amylase B hybrid acid alpha-amylase consisting of A. niger acid alpha- amylase catalytic domain (SEQ ID NO: 38)-A kawachii glucoamylase linker (SEQ ID NO: 38)
  • - A. kawachii glucoamylase CBD (SEQ ID NO: 2).
  • - Alpha-Amylase C Hybrid alpha-amylase shown in SEQ ID NO: 44 comprising a catalytic domain (CD) from Rhizomucor pusillus alpha-amylase having a carbohydrate-binding domain (CBD) from the Athelia rolfsii glucoamylase.
  • Enzyme classification numbers (EC numbers) referred to in the present specification with claims are in accordance with the Recommendations (1992) of the Nomenclature Committee of the International Union of Biochemistry and Molecular
  • Vlisco fabric from Vlisco BV, NL
  • Citric acid monohydrate 1.376 g of Citric acid monohydrate and 1.015 g of Sodium Citrate dihydrate are dissolved in 1 L of de-ionized water.
  • the degree of homology is determined as the degree of identity between two amino acid sequences as determined by the Clustal method (Higgins, 1989, CABIOS 5: 151-153) using the LASERGENETM
  • AFAU Acid Fungal Alpha-amylase Units
  • 1 FAU is defined as the amount of enzyme which degrades 5.260 mg starch dry matter per hour under the below mentioned standard conditions.
  • Acid alpha-amylase an endo-alpha-amylase (1 ,4-alpha-D-glucan-glucano- hydrolase, E.G. 3.2.1.1) hydrolyzes alpha-1 ,4-glucosidic bonds in the inner regions of the starch molecule to form dextrins and oligosaccharides with different chain lengths.
  • the intensity of color formed with iodine is directly proportional to the concentration of starch.
  • Amylase activity is determined using reverse colorimetry as a reduction in the concentration of starch under the specified analytical conditions.
  • KNU Alpha-amylase activity
  • the amylolytic activity may be determined using potato starch as substrate. This method is based on the break-down of modified potato starch by the enzyme, and the reaction is followed by mixing samples of the starch/enzyme solution with an iodine solution. Initially, a blackish-blue color is formed, but during the break-down of the starch the blue color gets weaker and gradually turns into a reddish-brown, which is compared to a colored glass standard.
  • KNU Kilo Novo alpha amylase Unit
  • FAU Fungal Alpha-Amylase Unit
  • the starch size residue is determined visually by comparing an iodine stained fabric swatch to a standard set of photos with 1-9 scale where 1 is dark blue and 9 has no color stain.
  • the iodine stain solution is made by dissolving 10 g Kl in 10 ml water, add 0.635g I 2 , and 20OmL ethanol in deionized water to make total 1 L solution.
  • a fabric sample is cut and immersed in the iodine solution for 60 seconds and rinsed in deionized water for about 5 seconds.
  • the fabric sample is rated by at least two professionals after excess water in the sample is pressed out. An average number is given.
  • Method and standard scales obtainable from Verband TEGEWA, Karlstrasse
  • a 100% cotton fabric (270g/m 2 ) was from Boras Wafveri Kungsfors AB, Sweden. It was made in 2003 with Cupper 3/1 construction.
  • the fabric contained 28 thread/cm warp yarn and 14 thread/cm weft yarn.
  • the warp yarn has Ne 11 and the weft has Ne 8. Both yarns were open end.
  • the dry size pick up on the warp yarn was 8%.
  • the size contained mainly Kollotex 5, Solvitose XO, and beef tallow wax with emulsifier.
  • Kollotex 5 is a low viscous potato starch ester.
  • Solvitose XO is a high viscous starch ether with DS about 0.07. Fabric swatches were cut to about 25g each.
  • Buffer pH2 was made by dissolving 11.53g 85% phosphoric acid in 4.5 liter pure water, titrating with 5N HCI to pH 1.95, then adding water to 5 liter.
  • Buffer pH3 was made by dissolving 11.53g 85% phosphoric acid in 4.5 liter pure water, titrating with 5N NaOH to pH 2.95, then adding water to 10 liter.
  • Buffer pH4 was made by dissolving 6.005g acetic acid in 4.5 liter pure water, titrating with 5N HCI to pH 3.95, then adding water to 10 liter.
  • a 2g/l nonionic surfactant was added in each buffer. The measured final pH values of these three buffers were 2, 2.99, and 3.98, respectively.
  • the fabric swatch was stained with an iodine solution.
  • the stained fabric sample was visually compared to TEGEWA standard photos with 1-9 scale where 1 is dark and 9 has no color stain. Thus higher number indicates a better starch removal.
  • the visual evaluation was done by at least three professionals and an average TEGEWA value was given for each fabric sample. The results are shown in Table 1.
  • the wild type acid Alpha-Amylase A treated fabric gave higher TEGEWA value than the fabric treated with no enzyme control at all three pH conditions, indicating that acid Alpha-Amylase A hydrolyzed and removed starch size on fabric. Increased enzyme activity resulted in higher TEGEWA indicating increased starch removal.
  • Acid Alpha-Amylase B was different from the wild-type Acid Alpha-Amylase A used in Example 1 in that the enzyme protein was constructed to comprise the wild-type Acid Alpha-Amylase A from A. niger (Example 1) linked with a CBD from Aspergillus kawachii acid alpha-amylase.
  • the enzyme used in this study has an activity of 316 AFAU/g.
  • the same treatments and measurements were conducted as in Example 1. The results are shown in Table 1. Acid Alpha-Amylase B with CBD gave higher TEGEWA value than wild-type acid Alpha-Amylase A at the same activity at all conditions, indicating that Acid Alpha-Amylase B with CBD improves alpha-amylase desizing performance.
  • Example 2 The same fabric swatches were prepared as in Example 1.
  • Buffer pH3 was made by dissolving 11.53g 85% phosphoric acid in 4.5 liter pure water, titrating with 5N NaOH to pH 2.95, then adding water to 5 liter. After adding 2g/l nonionic surfactant (a wetting agent) in the buffer, the buffer pH was measured as 3.05 at 25 0 C. The same enzyme as in Example 1 was used.
  • the desizing treatment was conducted in a Lab-o-mat (Werner Mathis). A 25OmL buffer solution was added in each beaker. A given amount of alpha-amylase enzyme was added. One fabric swatch (25g) was placed in each beaker. The beaker was closed and placed in the Lab-o-mat. Beakers were heated at 5°C/min to
  • Example 1 The results are shown in Table 2. The same conclusions in Example 1 can be drawn. A TEGEWA value of above 5 was achieved in lab equipment, indicating desizing at acidic condition is viable approach.
  • the residue of metal ions on fabric was also evaluated.
  • the fabric was first cut through 1 mm sieve with a Thomas-Wiley mill. Fabric mash 4.00 (+/-0.01) g was mixed with 80 mL 1g/L EDTA solution. The mixture was incubated at 7O 0 C and 200 rpm in a shaker (new Brunswick Scientific Co. Inc, Series 25) for 15 hours. After cooled down for about 30 minutes, the mixture was centrifuged at 2500 rpm at 2O 0 C for 10 minutes. The supernatant was collected for metal content analysis with a Perkinelmer atomic absorption spectrophometer.
  • Example 2 Essentially the same set of experiments was conducted in the same way as in the Example 3, except the alpha-amylase in Example 2 was used instead. The same experimental conditions and evaluation were carried out. The results are shown in
  • Example 2 Much higher TEGEWA value was obtained in this experiment, and the highest value was 5.8.
  • Example 2 The same type of fabric from Boras Wafveri Kungsfors AB (Sweden) as in Example 1 was used and the swatch was cut to about 62g each.
  • Buffer pH4 was made by dissolving 12.01g acetic acid in 4.5 liter pure water, titrating with 5N HCI to pH 3.95, then adding water to 10 liter.
  • a 2g/l nonionic surfactant (wetting agent) was added the buffer.
  • the final pH value of the buffer was 3.99.
  • Example 2 The same evaluation as in Example 1 was conducted. The results are shown in Table 3. Starch size on cotton fabric were hydrolyzed by alpha-amylase and removed during desizing process. At pH4, both amylase enzymes were able to perform desizing at both 2O 0 C and 4O 0 C.
  • Alpha-Amylase D for desizinq fabric at pH 4.0 De-ionized water was filled into beakers, up to 13 cm from the bottom. The water temperature was adjusted to 6O 0 C. 200 ml of 10 mM Citrate buffer (pH 4.0) was added to each beaker and placed in a Lab-o-Mat. The solutions were heated to 60 0 C. Different amounts of Alpha-Amylase D were added to the buffer. The final enzyme concentrations were 50FAU/L, 100FAU/L, 200FAU/L and 400FAU/L, respectively. Two swatches of Vlisco fabric were fixed in a pair of forceps and dipped in the impregnation bath for 30 seconds and then padded. The dipping and squeezing was repeated. The wet pick up was about 100%.
  • Example 6 The desizing procedure described in Example 6 was repeated, except that Alpha-Amylase C was used. The result of the tests is shown in Fig. 2.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Textile Engineering (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Detergent Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

L'invention porte sur un procédé de désencollage d'un tissu encollé contenant de l'amidon ou des dérivés de l'amidon pendant la fabrication d'un tissu, ledit procédé consistant à incuber ledit tissu encollé dans une solution de traitement aqueuse dont le pH est compris entre 1 et 5, ladite solution de traitement aqueuse renfermant une alpha-amylase.
EP05826499.5A 2004-12-02 2005-12-01 Procede de desencollage Withdrawn EP1888835A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63261104P 2004-12-02 2004-12-02
PCT/US2005/044044 WO2006065579A2 (fr) 2004-12-02 2005-12-01 Procede de desencollage

Publications (2)

Publication Number Publication Date
EP1888835A2 true EP1888835A2 (fr) 2008-02-20
EP1888835A4 EP1888835A4 (fr) 2013-11-13

Family

ID=36588373

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05826499.5A Withdrawn EP1888835A4 (fr) 2004-12-02 2005-12-01 Procede de desencollage

Country Status (6)

Country Link
US (1) US20090317893A1 (fr)
EP (1) EP1888835A4 (fr)
CN (1) CN101437999A (fr)
BR (1) BRPI0516653A2 (fr)
MX (1) MX2007005926A (fr)
WO (1) WO2006065579A2 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011203101B2 (en) * 2004-12-22 2012-11-08 Novozymes A/S Enzymes for starch processing
US8841091B2 (en) 2004-12-22 2014-09-23 Novozymes Als Enzymes for starch processing
ES2543131T3 (es) * 2004-12-22 2015-08-14 Novozymes North America, Inc. Enzimas para tratamiento de almidón
WO2007147835A1 (fr) * 2006-06-22 2007-12-27 Novozymes A/S Préparation de farine et de produits cuits
CN101070656B (zh) * 2007-06-18 2010-12-15 湖南华升株洲雪松有限公司 一种特高支纯苎麻织物制作方法及其制品
JP4792134B2 (ja) 2009-08-18 2011-10-12 グリコ栄養食品株式会社 澱粉ゲル含有食品
US9963581B2 (en) 2009-08-18 2018-05-08 Glico Nutrition Co., Ltd. Food product containing starch gel, starch granule, production method and use thereof
RU2471906C2 (ru) * 2010-10-22 2013-01-10 Российская Федерация, От Имени Которой Выступает Министерство Промышленности И Торговли Российской Федерации Способ получения хлопчатобумажной ткани технического назначения с комплексом защитных свойств от кислот и нефтепродуктов
WO2012111327A1 (fr) * 2011-02-16 2012-08-23 グリコ栄養食品株式会社 Produit alimentaire contenant un gel d'amidon de riz
CN102926184B (zh) * 2012-11-28 2015-07-29 华纺股份有限公司 涤棉织物前处理方法
WO2014086659A2 (fr) * 2012-12-06 2014-06-12 Ahmedabad Textile Industry's Research Association Procédé pour le traitement enzymatique de préparation de textiles
CN102978894B (zh) * 2012-12-11 2014-08-13 愉悦家纺有限公司 一种印染前处理工艺
CN103437140A (zh) * 2013-08-20 2013-12-11 如皋市五山漂染有限责任公司 一种精梳涤棉漂白布的前处理工艺
CN104313891B (zh) * 2014-10-17 2016-12-07 苏州大学 一种以超临界二氧化碳为介质的淀粉浆退浆方法
CN104831516A (zh) * 2015-04-02 2015-08-12 刘飞 精梳涤棉漂白布的前处理工艺
CN106222989A (zh) * 2016-08-30 2016-12-14 苏州紫澜实业有限公司 摇粒绒织物的退浆处理方法
CN106192355A (zh) * 2016-08-30 2016-12-07 苏州紫澜实业有限公司 仿羊绒织物的退浆处理方法
CN106222990A (zh) * 2016-08-30 2016-12-14 苏州紫澜实业有限公司 不倒绒织物的退浆处理方法
CN106192356A (zh) * 2016-08-30 2016-12-07 苏州紫澜实业有限公司 Pv绒织物的退浆处理方法
CN106222995A (zh) * 2016-08-31 2016-12-14 常熟市华裕知识产权咨询服务有限公司 苎麻织物的退浆处理方法
CN106222994A (zh) * 2016-08-31 2016-12-14 常熟市华裕知识产权咨询服务有限公司 羊毛织物的退浆处理方法
CN106120291A (zh) * 2016-08-31 2016-11-16 常熟市华裕知识产权咨询服务有限公司 亚麻织物的退浆处理方法
CN106222993A (zh) * 2016-08-31 2016-12-14 常熟市华裕知识产权咨询服务有限公司 纯棉织物的退浆处理方法
CN106149346A (zh) * 2016-08-31 2016-11-23 常熟市勤晟鑫纺织品贸易有限公司 涤棉麻混纺织物的退浆处理方法
CN106381675A (zh) * 2016-08-31 2017-02-08 常熟市勤晟鑫纺织品贸易有限公司 精纺毛织物的退浆处理方法
CN106192357A (zh) * 2016-08-31 2016-12-07 常熟市华裕知识产权咨询服务有限公司 维棉混纺织物的退浆处理方法
CN108166240A (zh) * 2017-12-15 2018-06-15 纤化（上海）生物化工股份有限公司 一种牛仔成衣退浆精练整理剂及其制备工艺

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0184019A1 (fr) * 1984-11-09 1986-06-11 Hitachi, Ltd. Bactérie anaérobe thermophile, productrice d'une alpha-amylase thermostable, alpha-amylase thermostable et leur procédé de préparation
WO2002010355A2 (fr) * 2000-08-01 2002-02-07 Novozymes A/S Mutants d'alpha-amylase a proprietes modifiees
WO2003068976A2 (fr) * 2002-02-14 2003-08-21 Novozymes A/S Procede de preparation d'amidon
WO2004055178A1 (fr) * 2002-12-17 2004-07-01 Novozymes A/S Alpha-amylases thermostables
WO2004065683A1 (fr) * 2003-01-17 2004-08-05 Cht R. Beitlich Gmbh Procede pour le finissage de matieres fibreuses textiles

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3626203B2 (ja) * 1995-11-15 2005-03-02 ノボザイムス アクティーゼルスカブ 染色されたデニムの複合糊抜及び「ストーンウォッシュ」方法
CN1209838A (zh) * 1996-01-29 1999-03-03 诺沃挪第克公司 纤维素织物的脱浆方法
JP5571274B2 (ja) * 2000-03-08 2014-08-13 ノボザイムス アクティーゼルスカブ 改変された特性を有する変異体
DE10205929A1 (de) * 2002-02-12 2003-08-21 Cognis Deutschland Gmbh Verfahren zum gleichzeitigen enzymatischen Entschlichten und Abkochen von cellulosehaltigem Material
AU2003301185A1 (en) * 2002-12-20 2004-07-22 Novozymes North America, Inc. Treatment of fabrics, fibers, or yarns
ES2425351T3 (es) * 2003-06-25 2013-10-14 Novozymes A/S Polipéptidos que tienen actividad de alfa-amilasa y polinucleótidos que codifican los mismos

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0184019A1 (fr) * 1984-11-09 1986-06-11 Hitachi, Ltd. Bactérie anaérobe thermophile, productrice d'une alpha-amylase thermostable, alpha-amylase thermostable et leur procédé de préparation
WO2002010355A2 (fr) * 2000-08-01 2002-02-07 Novozymes A/S Mutants d'alpha-amylase a proprietes modifiees
WO2003068976A2 (fr) * 2002-02-14 2003-08-21 Novozymes A/S Procede de preparation d'amidon
WO2004055178A1 (fr) * 2002-12-17 2004-07-01 Novozymes A/S Alpha-amylases thermostables
WO2004065683A1 (fr) * 2003-01-17 2004-08-05 Cht R. Beitlich Gmbh Procede pour le finissage de matieres fibreuses textiles

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [Online] E.B.I. Hinxton U.K.; 1 January 1998 (1998-01-01), Kaneko A et al: "Acid stable alpha-amylase", XP002713770, Database accession no. O13296 *
See also references of WO2006065579A2 *

Also Published As

Publication number Publication date
US20090317893A1 (en) 2009-12-24
WO2006065579A3 (fr) 2012-07-19
WO2006065579A9 (fr) 2006-11-30
CN101437999A (zh) 2009-05-20
MX2007005926A (es) 2008-10-24
BRPI0516653A2 (pt) 2012-07-31
EP1888835A4 (fr) 2013-11-13
WO2006065579A2 (fr) 2006-06-22

Similar Documents

Publication Publication Date Title
US20090317893A1 (en) Desizing process
EP2041278B1 (fr) Procédé de désensimage et de dégorgeage
US20070243596A1 (en) Simultaneous Desizing and Scouring Process
JP3661995B2 (ja) 放線菌類により産生されるセルラーゼとその産生方法
CN111670250B (zh) 真菌纤维素酶的变体
BRPI0620318B1 (pt) proteína de fusão endoglicanase, polinucleotídeo isolado, vetor de expressão, célula hospedeira de trichoderma reesei, preparação de enzima, composição detergente, cepa de escherichia coli, e processos para produção de um polipeptídeo endoglicanase, para bioestonagem, para bioacabamento, para tratamento de material têxtil contendo fibra celulósica, para tratamento de polpa ou fibra derivada de madeira, e para aperfeiçoamento de qualidade de alimentação animal
US20070148732A1 (en) Novel enzymes
US20130295651A1 (en) Method for Treating Textile with Endoglucanase
CN102943391A (zh) 生物抛光和漂白清洁组合的方法
Puranen et al. Trichoderma enzymes for textile industries
US20220380974A1 (en) Enzymatic treatment of cellulosic textile
EP3553172B1 (fr) Procédé de traitement d'un textile au moyen d'une endoglucanase
EP2659058A1 (fr) Procédé permettant de traiter un textile à l'aide d'un polypeptide qui est doté d'une activité d'amélioration de l'enzyme cellulolytique
US6294366B1 (en) Compositions and methods for treating cellulose containing fabrics using truncated cellulase enzyme compositions
WO2014086659A2 (fr) Procédé pour le traitement enzymatique de préparation de textiles
US9328456B2 (en) Method for treating textile with endoglucanase
Mojsov Role of biotechnology in textile industry: A review

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK YU

DAX Request for extension of the european patent (deleted)
R17D Deferred search report published (corrected)

Effective date: 20120719

RIC1 Information provided on ipc code assigned before grant

Ipc: C12P 1/00 20060101AFI20120727BHEP

17P Request for examination filed

Effective date: 20130121

RBV Designated contracting states (corrected)

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

A4 Supplementary search report drawn up and despatched

Effective date: 20131015

RIC1 Information provided on ipc code assigned before grant

Ipc: D06M 16/00 20060101ALI20131007BHEP

Ipc: C12P 1/00 20060101ALI20131007BHEP

Ipc: C12N 9/30 20060101ALI20131007BHEP

Ipc: C12N 9/28 20060101ALI20131007BHEP

Ipc: D06L 1/14 20060101AFI20131007BHEP

17Q First examination report despatched

Effective date: 20140606

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20141017